Literature DB >> 28351465

The Natural Course and Treatment of ADHD, and Its Place in Adulthood.

Ingrid Schubert1, Gerd Lehmkuhl.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28351465      PMCID： PMC5378978          DOI： 10.3238/arztebl.2017.0139

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  6 in total

Review 1.  [Time Trends in the Frequencies of ADHD and Stimulant Medication].

Authors:  Hans-Christoph Steinhausen; Manfred Döpfner; Ingrid Schubert
Journal:  Z Kinder Jugendpsychiatr Psychother       Date:  2016

2.  [Has the prevalence of parent-reported diagnosis of attention deficit hyperactivity disorder (ADHD) in Germany increased between 2003-2006 and 2009-2012? Results of the KiGGS-study: first follow-up (KiGGS Wave 1)].

Authors:  R Schlack; E Mauz; J Hebebrand; H Hölling
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2014-07       Impact factor: 1.513

3. 

Authors:  Jörg M Fegert; Iris Hauth; Tobias Banaschewski; Harald J Freyberger
Journal:  Z Kinder Jugendpsychiatr Psychother       Date:  2017-01

4.  [Management of children, adolescents and adults with attention deficit/hyperactivity disorder (ADHD) in Germany. Position of the central adhd network for 2009 special expert assessment by the medical expert on evaluation of development in public health].

Authors:  Manfred Döpfner; Tobias Banaschewski; Johanna Krause; Klaus Skrodzki
Journal:  Z Kinder Jugendpsychiatr Psychother       Date:  2010-03

Review 5.  Attention-Deficit/Hyperactivity Disorder.

Authors:  Tobias Banaschewski; Katja Becker; Manfred Döpfner; Martin Holtmann; Michael Rösler; Marcel Romanos
Journal:  Dtsch Arztebl Int       Date:  2017-03-03       Impact factor: 5.594

Review 6.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630
  6 in total
  2 in total

Review 1.  Pharmacological Neuroenhancement: Current Aspects of Categorization, Epidemiology, Pharmacology, Drug Development, Ethics, and Future Perspectives.

Authors:  Johanna Daubner; Muhammad Imran Arshaad; Christina Henseler; Jürgen Hescheler; Dan Ehninger; Karl Broich; Oliver Rawashdeh; Anna Papazoglou; Marco Weiergräber
Journal:  Neural Plast       Date:  2021-01-13       Impact factor: 3.599

2.  The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany.

Authors:  Thomas Grimmsmann; Wolfgang Himmel
Journal:  Eur J Clin Pharmacol       Date:  2020-08-17       Impact factor: 2.953
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.